Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bausch Health US, LLC v. Virtus Pharmaceuticals OPCO II, LLC
Case Number:
3:17-cv-06731
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 22, 2019
Valeant Copycat Drug Row Can Stay In Calif., Judge Rules
A unit of Valeant Pharmaceuticals can keep its false drug marketing claims against a subsidiary of rival Virtus Pharmaceuticals in California federal court, a judge has ruled, finding the dispute didn't have to go through the U.S. Food and Drug Administration first.
-
October 25, 2018
Valeant Poised To Pursue Label Suits Over IBS Drug Copycats
A California federal judge said Thursday he'll likely allow Valeant to proceed with lawsuits alleging two pharmaceutical companies falsely advertised U.S. Food and Drug Administration approval of copycat versions of its irritable bowel syndrome drug, saying he didn't buy arguments that potential appeals to the FDA preempted the suits.